ECL · 10-Q · 2026Q2 · Full report

Life Sciences Market Growth

ECOLAB INC. · 2026-08-06 · Importance 54 · Surprise 40 · From source text

Global Life Sciences organic sales increased 15% in the second quarter and 13% in the first six months of 2026, exceeding the materiality threshold for year-over-year growth. Demand remained strong in bioprocessing and pharmaceuticals and personal care, while purification growth improved. Higher volume, pricing and a spike in bioprocessing drove significant operating-margin expansion. Investments in the business and higher commodity costs partially offset those market-driven benefits.

Key facts

• Fixed currency operating income for Global Life Sciences in Q2 2026 was $58.5 million and in Q2 2025 was $40.2 million. source
• Global Life Sciences fixed currency and organic sales increased 15% in Q2 2026 and 13% in the first six months of 2026. source
• Global Life Sciences organic operating income margins increased 5.5 percentage points in Q2 2026 due to a 9.0 point positive impact from higher volume, pricing and a spike in bioprocessing partially offset by a 2.9 point negative impact from investments and higher commodity costs. source
• Global Life Sciences fixed currency operating income margin in Q2 2026 was 26.5% and in Q2 2025 was 21.0%. source

Impact estimates